IRIS UniCatt

Iorio, Raffaele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.556
EU - Europa 4.082
AS - Asia 4.078
SA - Sud America 904
AF - Africa 114
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.756
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.378
SG - Singapore 1.766
DE - Germania 1.510
CN - Cina 1.062
BR - Brasile 715
SE - Svezia 591
IT - Italia 442
VN - Vietnam 393
FR - Francia 355
UA - Ucraina 287
GB - Regno Unito 220
IN - India 202
IE - Irlanda 166
FI - Finlandia 151
ID - Indonesia 116
RU - Federazione Russa 94
JP - Giappone 91
CA - Canada 90
HK - Hong Kong 83
AR - Argentina 63
TR - Turchia 62
MX - Messico 57
PL - Polonia 56
IQ - Iraq 47
BD - Bangladesh 46
BE - Belgio 34
EC - Ecuador 34
KR - Corea 32
NL - Olanda 32
CI - Costa d'Avorio 31
AT - Austria 28
ES - Italia 26
ZA - Sudafrica 25
PK - Pakistan 24
CO - Colombia 23
SA - Arabia Saudita 23
UZ - Uzbekistan 19
PY - Paraguay 18
VE - Venezuela 18
CH - Svizzera 16
LT - Lituania 15
CL - Cile 14
IR - Iran 14
MA - Marocco 14
AU - Australia 13
JO - Giordania 11
KE - Kenya 11
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
EG - Egitto 9
OM - Oman 8
IL - Israele 7
NP - Nepal 7
PH - Filippine 7
TN - Tunisia 7
UY - Uruguay 7
DZ - Algeria 6
PE - Perù 6
PT - Portogallo 6
BO - Bolivia 5
BY - Bielorussia 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
KZ - Kazakistan 5
LV - Lettonia 5
MY - Malesia 5
RO - Romania 5
A2 - ???statistics.table.value.countryCode.A2??? 4
MD - Moldavia 4
NI - Nicaragua 4
PA - Panama 4
RS - Serbia 4
AL - Albania 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GR - Grecia 3
JM - Giamaica 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MM - Myanmar 3
NO - Norvegia 3
PS - Palestinian Territory 3
DK - Danimarca 2
EE - Estonia 2
GT - Guatemala 2
HN - Honduras 2
KW - Kuwait 2
LB - Libano 2
LY - Libia 2
MN - Mongolia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AO - Angola 1
Totale 14.733
Salva come PNG Salva come JPEG
Città #
Singapore 937
Ashburn 685
Chandler 684
San Jose 513
Beijing 213
New York 211
Jacksonville 206
Ann Arbor 180
Dublin 157
Ho Chi Minh City 142
Los Angeles 136
San Mateo 131
Hefei 130
Lauterbourg 106
Nanjing 105
Nürnberg 100
Hanoi 97
Jakarta 96
Chicago 90
Woodbridge 86
Dearborn 85
Rome 82
Houston 77
Tokyo 77
Frankfurt am Main 76
Munich 75
Hong Kong 74
São Paulo 68
Wilmington 68
Milan 60
Boston 58
Dallas 57
Marseille 51
Bremen 49
Buffalo 49
Cattolica 48
Moscow 48
Helsinki 47
Orem 47
North Bergen 43
Santa Clara 41
Lawrence 39
Princeton 39
Redmond 38
Redwood City 36
Kent 35
Nanchang 35
Seattle 35
Warsaw 35
Brussels 34
Izmir 34
Turku 32
Abidjan 31
Seoul 31
Düsseldorf 30
London 30
Norwalk 30
Council Bluffs 29
The Dalles 29
Hangzhou 27
Montreal 27
Nuremberg 27
Shanghai 25
Atlanta 24
Chennai 24
Denver 21
Mexico City 21
Paris 21
Boardman 20
Detroit 20
Mountain View 20
Phoenix 20
Pune 20
Shenyang 20
Amsterdam 19
Brooklyn 19
Ottawa 19
St Louis 19
Poplar 18
Rio de Janeiro 18
Stockholm 18
Tianjin 18
Belo Horizonte 17
Johannesburg 17
Tashkent 17
University Park 17
Baghdad 16
Monza 16
Trieste 16
Da Nang 15
Fairfield 15
Manchester 15
Salvador 15
San Francisco 15
Changsha 14
Leawood 14
Lappeenranta 13
Dhaka 12
Hebei 12
Quito 12
Totale 7.640
Salva come PNG Salva come JPEG
Nome #
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 264
pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. 244
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 238
T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. 235
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 232
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 219
Acute necrotizing Encephalopathy during novel influenza A (H1N!) virus infection 207
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study 204
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies 195
Assessment of neurological manifestations in hospitalized patients with COVID-19 194
Multiple Sclerosis attacks triggered by hyperprolactinemia 193
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 192
Poly-autoimmunity in patients with myasthenia gravis: A single-center experience 188
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 186
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 186
Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma 183
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 180
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 178
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. 173
Remission of myasthenia gravis with MuSK antibodies during ruxolitinib treatment 173
Circulating CD8+CD56-Perforin+ T cells are increased in Multiple Sclerosis patients 171
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 169
Epstein-Barr virus antibodies in serum and cerebrospinal fluid from Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Amyotrophic Lateral 167
Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis 166
Copper deficiency myelopathy: A report of two cases 165
Type 1 immune response in progressive Multiple Sclerosis 164
A Case of Hemiabdominal Myoclonus 164
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 163
Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment. 163
3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies 162
Replay to Influenza A (H1N1) in cerebrospinal fluid sample and encephalopathy by Sandoval-Gutiérrez JM, Arcos M, Alva L, Volkow P, T Ferrari T, Quiñones F, Vázquez-Pérez J, Ormsby JE, Hanssen F, Reséndiz A, Alcántara P, Pérez Padilla R, Bautista E. 161
Myasthenia gravis with antibodies to MuSK: an update 159
A b3 type-thymoma in a 7-year-old child with myasthenia gravis 157
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? 154
CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment 153
Complement inhibitor therapy as a steroid-sparing strategy in generalized myasthenia gravis 152
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 152
CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients 151
Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations 150
Clinical characteristics and outcome of patients with autoimmune encephalitis: clues for paraneoplastic etiology 148
Increased CD4(+)CD25(+)Foxp3(+) T Cells in Peripheral Blood of Celiac Disease Patients: Correlation with Dietary Treatment. 146
IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. 145
Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer. 142
Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients 140
The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. 140
Pattern of ocular involvement in myasthenia gravis with MuSK antibodies 139
Resolution of muscle inflammation after tumor removal in a woman with paraneoplastic dermatomyositis 136
Myasthenia gravis with presynaptic neurophysiological signs: Two case reports and literature review 136
Breastfeeding and multiple sclerosis 135
Efficacy and safety of rituximab therapy in neuromyelitis optica spectrum disorders: A systematic review and meta-analysis 134
gc) Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment. 131
Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia? 131
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 131
A Case of Hemiabdominal Myoclonus 130
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 130
Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia 129
Teaching NeuroImages: Transient mutism associated with splenium lesion in capecitabine-induced leukoencephalopathy 126
SIADH in a patient with sensory ataxic neuropathy with anti-disialosyl antibodies (CANOMAD) 124
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies 122
Glioblastoma in multiple sclerosis: a case report 122
Post-Encephalitic Parkinsonism and Sleep Disorder Responsive to Immunological Treatment: A Case Report 120
Post-Encephalitic Parkinsonism and Sleep Disorder Responsive to Immunological Treatment: A Case Report 118
A score that predicts aquaporin-4 IgG positivity in patients with longitudinally extensive transverse myelitis 117
Multiple sclerosis attacks triggered by hyperprolactinemia 116
Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies 116
Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor 114
Regulatory T cells fail to suppress CD4(+)T-bet(+) T cells in relapsing multiple sclerosis patients 114
Imaging Features of Varicella Zoster Virus Cranial Multiple Mononeuropathies 114
Cancer Frequency in MuSK Myasthenia Gravis and Histological Evidence of Paraneoplastic Etiology 111
Ravulizumab for generalized Myasthenia Gravis: a multicenter real-life experience 111
gc)Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 111
The detection of neural autoantibodies in patients with antiepileptic-drug-resistant epilepsy predicts response to immunotherapy 111
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 110
Focal hyperhidrosis in tumefactive Multiple Sclerosis 109
gc) T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: new markers of disease activity. 108
Tuberculous nephritis accompanying neuromyelitis optica: causal or coincidental association? 108
Concordance between radioimmunoassay and fixed cell-based assay in subjects without myasthenia gravis: optimizing the diagnostic approach 106
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study 105
pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity 104
Controversies in Ocular Myasthenia Gravis 103
Nine syndrome 102
Assessment of neurological manifestations in hospitalized patients with COVID-19 98
Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations 98
Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (II) 97
Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4 96
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension 94
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study 91
Isolated Memory Loss in Anti-NMDAR Encephalitis 91
Movement disorders phenomenology in focal motor seizures 88
Real-world application of the updated diagnostic criteria for paraneoplastic neurological syndromes 86
Toxic leukoencephalopathy after intravenous heroin injection: a case with clinical and radiological reversibility 86
Complement inhibitor therapy in thymoma-associated myasthenia gravis: a real-world experience 82
Epilepsia Partialis Continua as a manifestation of aquaporin-4 autoimmunity 81
Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (I) 81
Thymoma resection and myasthenia gravis: what is the neurological outcome in patients older than 65 years? 80
The detection of neural autoantibodies in patients with antiepileptic-drug-resistant epilepsy predicts response to immunotherapy 80
Paraneoplastic neurological syndromes 77
Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens 75
Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations 74
Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-Antibody encephalitis 72
Totale 13.879
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.924
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.924
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021153 0 0 0 0 0 0 0 0 0 0 138 15
2021/2022802 75 48 24 74 41 18 22 101 36 62 123 178
2022/20231.856 200 248 148 307 98 225 98 159 241 52 52 28
2023/20241.034 36 247 36 113 26 188 69 44 18 29 112 116
2024/20252.184 36 81 146 80 115 58 96 98 347 200 461 466
2025/20265.696 939 179 368 862 1.050 251 877 288 378 485 19 0
Totale 14.974